Cargando…
Propentofylline Targets TROY, a Novel Microglial Signaling Pathway
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain cancer, with a median survival of less than 2 years after diagnosis with current available therapies. The tumor microenvironment serves a critical role in tumor invasion and progression, with microglia as a critical player...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359343/ https://www.ncbi.nlm.nih.gov/pubmed/22649568 http://dx.doi.org/10.1371/journal.pone.0037955 |